Login / Signup
Current trends with FOXP3+ regulatory T cell immunotherapy to contest autoimmunity and inflammation.
Trinath Jamma
Jagadeesh Bayry
Published in:
Immunotherapy (2019)
Keyphrases
</>
regulatory t cells
oxidative stress
transcription factor
celiac disease
dendritic cells